Clinical Trial Update: A Bioequivalence (BE) Study in Healthy Subjects [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 bioequivalence study in healthy volunteers evaluating an ADHD drug candidate from Eli Lilly; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• ADHD drug candidate (bioequivalence study)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 1 | Status: COMPLETED | Results posted: 2011-10-27